Major depressive disorder (MDD) is one of the leading causes of disability worldwide, and approximately 30% of patients develop treatment-resistant depression (TRD), a condition that does not respond ...

You spot signs of depression in someone you care about or in yourself and want a clear explanation. Research still shows no ...

LONG BEACH, CA - March 06, 2026 - PRESSADVANTAGE - Moment of Clarity has published a comprehensive new resource on its ...

The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...

Patients with major depressive disorder and patients with inflammatory skin diseases like atopic dermatitis share similar ...

Intra-Cellular Therapies’ surging antipsychotic Caplyta has scored again with remarkable trial results, fueling its bid for a third and potentially most lucrative indication—major depressive disorder ...

Depression is a complex and deeply personal experience. While almost everyone has periods of sadness, low mood or grief, depression is different. Major depressive disorder is persistent, interferes ...

Compared with usual care, use of the PETRUSHKA tool increased the number of patients still taking their antidepressant at 8 weeks and improved depressive and anxiety symptoms at 24 weeks. However, ...

The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder. Rejoyn, made by Otsuka Pharmaceutical and Click Therapeutics, ...

Dr.: There are well-established therapies that can help those afflicted with SAD to get through the dark winter months ...

This study suggests is that clinicians "may be able to offer patients a path to meaningful relief in less than 1 week." ...

Valerie Taylor's research explores links between gut bacteria and bipolar disorder, testing faecal microbiota transplants as potential treatments for mental illness.